Recent research sheds light on how changes in the chemical structure of a protein called Interleukin-6 affect lung cancer’s ...

Department of Nephrology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China ...

随着国人生活方式的变迁，脂肪肝患病率不断升高，其对IRI高度敏感，大量脂肪变性供肝被弃用，因此，解析脂肪肝IRI加重的分子机制有望利用脂肪变性供肝扩大供肝数量从而挽救更多终末期肝病患者生命。IRI由过度激活的炎症反应介导，而细胞因子及细胞因子受体在炎 ...

School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, Xi’an, Shaanxi 710129, P. R. of China ...

The funding announced Wednesday for the San Carlos, California-based company will support development of its therapy GLM101, which is designed to treat phosphomannomutase 2-congenital disorder of ...